Develogen AG
About:
A biology-driven drug discovery company developing novel therapies for diabetes and obesity
Website: http://www.develogen.com/
Top Investors: Atlas Venture, Omega Funds, AlpInvest Partners, Deutsche Venture Capital, Thuja Capital
Description:
Develogen is a biology-driven drug discovery company that is engaged in the development of therapies for diabetes and obesity. The company was founded in 1995 and is based in Georgia, United States.
Total Funding Amount:
$61.5M
Headquarters Location:
Göttingen, Niedersachsen, Germany
Founded Date:
1997-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2007-06-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai